Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.33 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.32 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28313743 | 0.82 | TSHR (0.44) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9654192 | 0.81 | ALDH1A1 (0.40) | ALDH1A1TSHRMAP3K7TAB1 | |
| SCHEMBL666919 | 0.81 | ALDH1A1 (0.40) | ALDH1A1TSHRMAP3K7TAB1 | |
| SCHEMBL3200879 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMAP3K7TAB1 | |
| SCHEMBL3200874 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMAP3K7TAB1 | |
| SCHEMBL27542945 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMAP3K7TAB1 | |
| SCHEMBL3292256 | 0.77 | ALDH1A1 (0.33) | ALDH1A1MAP3K7TAB1 | |
| SCHEMBL940837 | 0.77 | GABRP (0.30) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL3289816 | 0.77 | GLO1 (0.44) | ALDH1A1TSHRMAPTHPGD | |
| SCHEMBL12391156 | 0.76 | ALDH1A1 (0.36) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023136797-A2 | A BILAYER TABLET COMPOSITION COMPRISING AMORPHOUS DAPAGLIFLOZIN AND METFORMIN | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2023-07-20 | — | — | WO | claimed |
| EP-4212150-A1 | A BILAYER TABLET COMPOSITION COMPRISING AMORPHOUS DAPAGLIFLOZIN AND METFORMIN | SANOVEL ILAC SANAYI VE TICARET A.S. (TR) | 2023-07-19 | — | — | EP | claimed |
| US-10611871-B2 | Star polymers and compositions thereof | THE LUBRIZOL CORPORATION (US) | 2020-04-07 | — | — | US | claimed |
| US-20160008469-A9 | METHOD FOR PREPARING BIOMEDICAL METAL ALLOY MATERIAL WITH MULTI-DRUG DELIVERY SYSTEM | Kwungpook National University Industry Academic Cooperation Foundation (KR) | 2016-01-14 | — | — | US | claimed |
| US-20150202168-A1 | ORAL FILM FORMULATIONS COMPRISING DAPOXETINE AND TADALAFIL | Sanovel llac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2015-07-23 | — | — | US | claimed |
| EP-2698147-B1 | Oral Film Formulations Comprising Dapoxetine and Tadalafil | SANOVEL ILAC SANAYI VE TICARET AS (TR) | 2015-07-22 | — | — | EP | claimed |
| WO-2014027980-A1 | ORAL FILM FORMULATIONS COMPRISING DAPOXETINE AND TADALAFIL | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2014-02-20 | — | — | WO | claimed |
| EP-2698147-A1 | Oral Film Formulations Comprising Dapoxetine and Tadalafil | Sanovel Ilac Sanayi ve Ticaret A.S. (TR) | 2014-02-19 | — | — | EP | claimed |
| US-20130164346-A1 | METHOD FOR PREPARING BIOMEDICAL METAL ALLOY MATERIAL WITH MULTI-DRUG DELIVERY SYSTEM | Kwungpook National University Industry Academic Cooperation Foundation (KR) | 2013-06-27 | — | — | US | claimed |
| EP-1791420-A1 | INDICATOR GRANULAR MATERIAL | Mars, Incorporated (US) | 2007-06-06 | — | — | EP | claimed |
| WO-2006032353-A1 | INDICATOR GRANULAR MATERIAL | MARS INCORPORATED (US) | 2006-03-30 | — | — | WO | claimed |
| CN-118028547-A | Suede finishing agent for leather, finishing process and leather | 辛集市梅花皮业有限公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-3411339-B1 | PROCESS FOR AEROBIC NITRITATION OF AMMONIA | MICROVI BIOTECH INC (US) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023136797-A2 | A BILAYER TABLET COMPOSITION COMPRISING AMORPHOUS DAPAGLIFLOZIN AND METFORMIN | SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2023-07-20 | — | — | WO | disclosed |
| EP-4212150-A1 | A BILAYER TABLET COMPOSITION COMPRISING AMORPHOUS DAPAGLIFLOZIN AND METFORMIN | SANOVEL ILAC SANAYI VE TICARET A.S. (TR) | 2023-07-19 | — | — | EP | disclosed |
| US-4085020-A | Electrodeposition of aqueous dispersions of copolymers of polyethylenically unsaturated epoxy-amine adducts | DESOTO, INC. (US) | 1978-04-18 | — | — | US | disclosed |
| US-4085161-A | Electrodeposition of aqueous dispersions of copolymers of polyethylenically unsaturated epoxy adducts including blocked isocyanate monomer | DESOTO, INC. (US) | 1978-04-18 | — | — | US | disclosed |
| US-4036800-A | Electrodeposition of aqueous dispersions of amine functional urethane copolymers | DESOTO, INC. (US) | 1977-07-19 | — | — | US | disclosed |
| US-4033917-A | Electrodeposition of aqueous dispersions of copolymers of polyethylenically unsaturated epoxy-amine adducts | DESOTO, INC. (US) | 1977-07-05 | — | — | US | disclosed |
| US-3976615-A | ELECTRODEPOSITION, COATINGS | DESOTO, INC. (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202168-A1 | ORAL FILM FORMULATIONS COMPRISING DAPOXETINE AND TADALAFIL | PDE5A, PDE3A, PDE3B | ALDH1A1 1504/4885GABRP 2305/4885GABRD 2777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.